F. J. Couch, K. L. Nathanson, and K. Offit, Two decades after BRCA: setting paradigms in personalized cancer care and prevention, Science, vol.343, issue.6178, pp.1466-70, 2014.

, Oncogénétique en 2014-Consultations, laboratoires & prise en charge. décision cAàl, editor

J. Armstrong, M. Toscano, N. Kotchko, S. Friedman, M. D. Schwartz et al., Utilization and Outcomes of BRCA Genetic Testing and Counseling in a National Commercially Insured Population: The ABOUT Study, JAMA Oncol, vol.1, issue.9, pp.1251-60, 2015.

I. Slade, D. Riddell, C. Turnbull, H. Hanson, and N. Rahman, Development of cancer genetic services in the UK: A national consultation, 18. PubMed Central PMCID: PMCPMC4341881, vol.7, p.25722743, 2015.

H. S. Vig and C. Wang, The evolution of personalized cancer genetic counseling in the era of personalized medicine, Fam Cancer, vol.11, issue.3, p.22419176, 2012.

H. D. Nelson, R. Fu, K. Goddard, J. P. Mitchell, L. Okinaka-hu et al., Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: Systematic Review to Update the US Preventive Services Task Force Recommendation. U.S. Preventive Services Task Force Evidence Syntheses, formerly Systematic Evidence Reviews, 2013.

H. D. Nelson, M. Pappas, B. Zakher, J. P. Mitchell, L. Okinaka-hu et al., Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: a systematic review to update the U.S. Preventive Services Task Force recommendation, Ann Intern Med, vol.160, issue.4, pp.255-66, 2014.

K. L. Nathanson and S. M. Domchek, Therapeutic approaches for women predisposed to breast cancer, Annu Rev Med, vol.62, pp.295-306, 2011.

V. A. Moyer and U. Force, Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. Preventive Services Task Force recommendation statement, Ann Intern Med, vol.160, issue.4, p.24366376, 2014.

C. Julian-reynier, J. Mancini, E. Mouret-fourme, M. Gauthier-villars, V. Bonadona et al., Cancer risk management strategies and perceptions of unaffected women 5 years after predictive genetic testing for BRCA1/2 mutations, Eur J Hum Genet, vol.19, issue.5, pp.500-506, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00697966

M. D. Schwartz, C. Isaacs, K. D. Graves, E. Poggi, B. N. Peshkin et al., Long-term outcomes of BRCA1/BRCA2 testing: risk reduction and surveillance, Cancer, vol.118, issue.2, pp.510-517, 2012.

J. P. Gopie, M. M. Ter-kuile, R. Timman, M. A. Mureau, and A. Tibben, Impact of delayed implant and DIEP flap breast reconstruction on body image and sexual satisfaction: a prospective follow-up study, Psychooncology, vol.23, issue.1, pp.100-107, 2014.

C. Julian-reynier, R. Fabre, I. Coupier, D. Stoppa-lyonnet, C. Lasset et al., BRCA1/2 carriers: their childbearing plans and theoretical intentions about having preimplantation genetic diagnosis and prenatal diagnosis, Genet Med, vol.14, issue.5, pp.527-561, 2012.
URL : https://hal.archives-ouvertes.fr/hal-00697969

K. D. Graves, P. Vegella, E. A. Poggi, B. N. Peshkin, A. Tong et al., Long-term psychosocial outcomes of BRCA1/BRCA2 testing: differences across affected status and risk-reducing surgery choice, Cancer Epidemiol Biomarkers Prev, vol.21, issue.3, pp.445-55, 2012.

J. G. Hamilton, M. Lobel, and A. Moyer, Emotional distress following genetic testing for hereditary breast and ovarian cancer: a meta-analytic review, Health Psychol, vol.28, issue.4, pp.510-518, 2009.

H. A. Douglas, R. J. Hamilton, and R. E. Grubs, The effect of BRCA gene testing on family relationships: A thematic analysis of qualitative interviews, J Genet Couns, vol.18, issue.5, p.19479365, 2009.

J. Lapointe, K. Bouchard, A. F. Patenaude, E. Maunsell, J. Simard et al., Incidence and predictors of positive and negative effects of BRCA1/2 genetic testing on familial relationships: a 3-year follow-up study, Genet Med, vol.14, issue.1, pp.60-68, 2012.

J. Vos, F. Menko, A. M. Jansen, C. J. Van-asperen, A. M. Stiggelbout et al., A whisper-game perspective on the family communication of DNA-test results: a retrospective study on the communication process of BRCA1/2-test results between proband and relatives, Fam Cancer, vol.10, issue.1, p.20852944, 2011.

F. Eisinger, R. Fabre, C. Lasset, D. Stoppa-lyonnet, C. Julian-reynier et al., Spontaneous disclosure of BRCA1/2 genetic test results to employers: a French prospective study, Eur J Hum Genet, vol.20, issue.9, pp.981-984, 2012.
URL : https://hal.archives-ouvertes.fr/hal-02296998

K. Armstrong, J. Stopfer, K. Calzone, G. Fitzgerald, J. Coyne et al., What does my doctor think? Preferences for knowing the doctor's opinion among women considering clinical testing for BRCA1/2 mutations, Genet Test, vol.6, issue.2, pp.115-123, 2002.

A. M. Mccarthy, M. Bristol, S. M. Domchek, P. W. Groeneveld, Y. Kim et al., Health Care Segregation, Physician Recommendation, and Racial Disparities in BRCA1/2 Testing Among Women With Breast Cancer, J Clin Oncol, vol.34, issue.22, pp.2610-2618, 2016.

A. M. Mccarthy, M. Bristol, T. Fredricks, L. Wilkins, I. Roelfsema et al., Are physician recommendations for BRCA1/2 testing in patients with breast cancer appropriate? A population-based study. Cancer, vol.119, pp.3596-603, 2013.

D. Heijer, M. Van-asperen, C. J. Harris, H. Nippert, I. Schmidtke et al., International variation in physicians' attitudes towards prophylactic mastectomy-comparison between France, Germany, the Netherlands and the United Kingdom, Eur J Cancer, vol.49, issue.13, pp.2798-805, 2013.

M. D. Schwartz, C. Lerman, B. Brogan, B. N. Peshkin, C. H. Halbert et al., Impact of BRCA1/ BRCA2 counseling and testing on newly diagnosed breast cancer patients, J Clin Oncol, vol.22, issue.10, pp.1823-1832, 2004.

C. B. Terwee, S. D. Bot, M. R. De-boer, D. A. Van-der-windt, D. L. Knol et al., Quality criteria were proposed for measurement properties of health status questionnaires, J Clin Epidemiol, vol.60, issue.1, pp.34-42, 2007.

J. P. Guilford, Psychometric methods, 1954.

J. E. Ware and B. Gandek, Methods for testing data quality, scaling assumptions, and reliability: the IQOLA Project approach. International Quality of Life Assessment, J Clin Epidemiol, vol.51, issue.11, pp.945-52, 1998.

J. Nunnally and I. Bernstein, Psychometric theory, 1994.

J. P. Robinson, P. R. Shaver, L. S. Wrightsman, and F. M. Andrews, Measures of Personality and Social Psychological Attitudes, 1991.

D. Streiner and G. Norman, Health Measurement Scales, 2000.

B. Djulbegovic, A. Kumar, P. Glasziou, B. Miladinovic, and I. Chalmers, Medical research: Trial unpredictability yields predictable therapy gains, Nature, vol.500, issue.7463, pp.395-401, 2013.

D. Cella, C. Hughes, A. Peterman, C. H. Chang, B. N. Peshkin et al., A brief assessment of concerns associated with genetic testing for cancer: the Multidimensional Impact of Cancer Risk Assessment (MICRA) questionnaire, Health Psychol, vol.21, issue.6, pp.564-72, 2002.

W. Eijzenga, E. M. Bleiker, D. E. Hahn, I. Kluijt, G. N. Sidharta et al., Psychosocial aspects of hereditary cancer (PAHC) questionnaire: development and testing of a screening questionnaire for use in clinical cancer genetics, Psychooncology, vol.23, issue.8, pp.862-871, 2014.

M. Horowitz, N. Wilner, and W. Alvarez, Impact of Event Scale: a measure of subjective stress, Psychosom Med, vol.41, issue.3, pp.209-227, 1979.